Primary Care Clinics in Norway, MI Accepting Medicare
9 Primary Care Clinics found. Showing 1 - 9
 Marshfield Medical Center - Dickinson Norway Family And Geriatric Ctr Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 500 Main St, Norway, MI 49870 Phone: 906-563-9255 Fax: 906-563-9706 |
Michael E. Zevitz, M.d. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 400 Main St, Norway, MI 49870 Phone: 906-563-5800 |
Foundations Health & Physical Medicine Clinic/Center - Multi-Specialty Medicare: Medicare Enrolled Practice Location: 415 W Us Highway 2, Norway, MI 49870 Phone: 906-563-5800 Fax: 906-563-5809 |
Paul N. Hayes, Md Pc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 Main St, Norway, MI 49870 Phone: 906-563-9255 Fax: 906-563-9706 |
Bellin Health Norway Family Medicine Medicare: Not Enrolled in Medicare Practice Location: N1667 Us Highway 8, Norway, MI 49870 Phone: 906-563-7323 Fax: 906-563-7120 |
Marshfield Medical Center - Dickinson Norway Center Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: N1667 Us Highway 8, Norway, MI 49870 Phone: 906-563-7323 Fax: 906-563-7120 |
Michael E Zevitz Md Pc Internal Medicine Medicare: Medicare Enrolled Practice Location: 415 W Us Highway 2, Ste 2, Norway, MI 49870 Phone: 906-563-5800 Fax: 906-563-5809 |
Superior Family Health Center, P.c. Family Medicine Medicare: Medicare Enrolled Practice Location: 411 W Us Highway 2, Norway, MI 49870 Phone: 906-563-9600 Fax: 906-563-7110 |
David E Atkinson Md Pc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 Main St, Norway, MI 49870 Phone: 906-563-9255 Fax: 906-563-9706 |
News Archive
Economic impact of acute coronary syndrome goes beyond hospitals to homes and workplaces
The economic impact of a heart attack and other forms of acute coronary syndrome goes beyond the hospital to the home and workplace, according to research presented at the American Heart Association's Scientific Sessions 2012.
CBIS shares owned by Cannex Therapeutics to be cancelled and re-issued to K&D
Cannabis Science, Inc., a pioneering U.S. biotech company developing pharmaceutical cannabis products announces Federal Court order for CBIS shares owned by Cannex Therapeutics controlled by Steve Kubby to be cancelled and re-issued to K&D. Both K&D and Cannabis Science denounce the "slanderous, malicious attacks" on the Company by its fired CEO Steve Kubby.
AMT initiates dosing in Phase I/II gene therapy clinical trial for hemophilia B
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the first patient has been dosed in the Phase I/II exploratory clinical trial with a gene therapy product for hemophilia B, a seriously debilitating and potentially lethal disease.
EnVivo presents positive EVP-6124 Phase 2b trial data on schizophrenia at 50th ACNP meeting
EnVivo Pharmaceuticals, a company dedicated to developing a broad range of novel central nervous system (CNS) therapies, announced today that it is presenting the comprehensive analysis of a recently completed Phase 2b clinical trial of EVP-6124, a novel, orally bioavailable nicotinic alpha-7 agonist, in schizophrenia at the American College of Neuropsychopharmacology 50th Anniversary Annual Meeting.
› Verified 2 days ago